Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Cohen Research Report on PTSC 140 pages

Also, talking best case, what we would need is to get the 100 million our part from the J2.5 and in 2008 settle with a ton of the biggest ones first to take in twice as much the first year. Maybe , just Maybe we could get a .50eps for that year and shoot above $10 right off the bat.

OK, we are talking best case , right !

Share
New Message
Please login to post a reply